Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-28 | Mr. John GallagherCOO | -3,60k | 78,15k | Automatic Disposition | 21,69 | 33,07k | -9,83% |
| 2026-05-22 | Mr. Darryl Graham Andrew RawlingsFounder & Chair of the Board | 312,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,46M | 0,02% |
| 2026-05-22 | Mr. Simon WheelerExec. VP of International Business | -1,02k | 22,34k | Derivative Exercise and Sale | 21,86 - 21,98 | 24,24k | - |
| 2026-05-22 | Mr. Simon WheelerExec. VP of International Business | 1,15k | 0,00 | Derivative Exercise and Retained Stock | - | 24,24k | 4,99% |
| 2026-05-22 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -7,49k | 164,57k | Derivative Exercise and Sale | 21,86 - 21,98 | 176,38k | - |
| 2026-05-22 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | 11,55k | 0,00 | Derivative Exercise and Retained Stock | - | 176,38k | 7,01% |
| 2026-05-22 | Ms. Brenna McGibneyChief Administrative Officer | -3,44k | 75,55k | Derivative Exercise and Sale | 21,86 - 21,98 | 11,45k | - |
| 2026-05-22 | Ms. Brenna McGibneyChief Administrative Officer | 2,99k | 0,00 | Derivative Exercise and Retained Stock | - | 11,45k | 35,40% |
| 2026-05-25 | Mr. Fawwad QureshiCFO | -3,75k | 82,67k | Derivative Exercise and Sale | 21,86 - 22,17 | 2,08k | - |
| 2026-05-27 | Mr. Fawwad QureshiCFO | -3,92k | 87,07k | Automatic Disposition | 22,17 - 22,63 | 2,08k | -65,35% |
| 2026-05-22 | Mr. Asher Benjamin BearmanChief Legal Officer | 1,77k | 0,00 | Derivative Exercise and Retained Stock | - | 72,24k | 2,50% |
| 2026-05-22 | Mr. Asher Benjamin BearmanChief Legal Officer | -844,00 | 18,55k | Derivative Exercise and Sale | 21,86 - 21,98 | 72,24k | - |
| 2026-05-22 | Dr. Steve WeinrauchChief Veterinary & Product Officer | -1,18k | 25,93k | Derivative Exercise and Sale | 21,86 - 21,98 | 76,24k | - |
| 2026-05-22 | Mr. John GallagherCOO | 5,14k | 0,00 | Derivative Exercise and Retained Stock | - | 36,67k | 16,31% |
| 2026-05-22 | Mr. Fawwad QureshiCFO | -3,99k | 87,68k | Sale to Issuer | 21,98 | 2,08k | -65,72% |
| 2026-05-22 | Dr. Steve WeinrauchChief Veterinary & Product Officer | 3,68k | 0,00 | Derivative Exercise and Retained Stock | - | 76,24k | 5,07% |
| 2026-05-22 | Mr. Howard Elliot RubinIndependent Director | 318,00 | 0,00 | Derivative Exercise and Retained Stock | - | 232,87k | 0,14% |
| 2026-05-22 | Mr. Fawwad QureshiCFO | 9,99k | 0,00 | Derivative Exercise and Retained Stock | - | 2,08k | -126,30% |
| 2026-05-22 | Mr. Bradley S. PowellIndependent Director | 639,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,91k | 50,43% |
| 2026-05-22 | Mr. John GallagherCOO | -1,65k | 36,27k | Derivative Exercise and Sale | 21,86 - 21,98 | 36,67k | - |
| 2026-04-28 | Mr. John GallagherCOO | -431,00 | 11,84k | Automatic Disposition | 27,47 | 31,53k | -1,35% |
| 2026-03-30 | Mr. John GallagherCOO | -430,00 | 10,95k | Automatic Disposition | 25,47 | 31,96k | -1,33% |
| 2026-03-04 | Ms. Emily DreyerChief Revenue Officer | -7,79k | 219,32k | Verkauf | 28,15 | 35,63k | -17,95% |
| 2026-02-27 | Mr. John GallagherCOO | -5,28k | 140,08k | Automatic Disposition | 26,52 | 32,39k | -14,02% |
| 2026-02-27 | Mr. Fawwad QureshiCFO | -2,84k | 75,08k | Automatic Disposition | 26,46 | 0,00 | -100,00% |
| 2026-02-25 | Mr. Fawwad QureshiCFO | 2,84k | 0,00 | Derivative Exercise and Retained Stock | - | 2,84k | - |
| 2026-02-25 | Mr. Fawwad QureshiCFO | -913,00 | 24,38k | Derivative Exercise and Sale | 26,70 | 2,84k | - |
| 2026-02-25 | Mr. Fawwad QureshiCFO | -4,65k | 118,96k | Automatic Disposition | 25,61 | 2,84k | -62,08% |
| 2026-02-25 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | 2,74k | 0,00 | Derivative Exercise and Retained Stock | - | 164,83k | 1,69% |
| 2026-02-25 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -1,78k | 47,42k | Derivative Exercise and Sale | 26,70 | 164,83k | - |
| 2026-02-25 | Ms. Brenna McGibneyChief Administrative Officer | 303,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,45k | 3,72% |
| 2026-02-25 | Ms. Brenna McGibneyChief Administrative Officer | -343,00 | 9,16k | Derivative Exercise and Sale | 26,70 | 8,45k | - |
| 2026-02-25 | Dr. Steve WeinrauchChief Veterinary & Product Officer | 702,00 | 0,00 | Derivative Exercise and Retained Stock | - | 72,56k | 0,98% |
| 2026-02-25 | Dr. Steve WeinrauchChief Veterinary & Product Officer | -223,00 | 5,95k | Derivative Exercise and Sale | 26,70 | 72,56k | - |
| 2026-02-25 | Ms. Emily DreyerChief Revenue Officer | 1,38k | 0,00 | Derivative Exercise and Retained Stock | - | 43,42k | 3,29% |
| 2026-02-25 | Ms. Emily DreyerChief Revenue Officer | -443,00 | 11,83k | Derivative Exercise and Sale | 26,70 | 43,42k | - |
| 2026-02-25 | Mr. Asher Benjamin BearmanChief Legal Officer | 189,00 | 0,00 | Derivative Exercise and Retained Stock | - | 70,48k | 0,27% |
| 2026-02-25 | Mr. Asher Benjamin BearmanChief Legal Officer | -116,00 | 3,10k | Derivative Exercise and Sale | 26,70 | 70,48k | - |
| 2026-02-25 | Mr. John GallagherCOO | 956,00 | 0,00 | Derivative Exercise and Retained Stock | - | 37,67k | 2,60% |
| 2026-02-25 | Mr. John GallagherCOO | -304,00 | 8,12k | Derivative Exercise and Sale | 26,70 | 37,67k | - |
| 2026-02-25 | Mr. Simon WheelerExec. VP of International Business | 171,00 | 0,00 | Derivative Exercise and Retained Stock | - | 23,09k | 0,75% |
| 2026-02-25 | Mr. Simon WheelerExec. VP of International Business | -151,00 | 4,03k | Derivative Exercise and Sale | 26,70 | 23,09k | - |
| 2026-02-25 | Mr. Darryl Graham Andrew RawlingsFounder & Chair of the Board | 946,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,46M | 0,07% |
| 2026-02-22 | Ms. Brenna McGibneyChief Administrative Officer | 2,06k | 0,00 | Derivative Exercise and Retained Stock | - | 8,15k | 33,74% |
| 2026-02-22 | Ms. Brenna McGibneyChief Administrative Officer | -2,43k | 66,00k | Derivative Exercise and Sale | 27,16 | 8,15k | - |
| 2026-02-22 | Mr. Simon WheelerExec. VP of International Business | -1,40k | 38,13k | Derivative Exercise and Sale | 27,16 | 22,92k | - |
| 2026-02-22 | Mr. Simon WheelerExec. VP of International Business | 1,59k | 0,00 | Derivative Exercise and Retained Stock | - | 22,92k | 7,44% |
| 2026-02-22 | Mr. Howard Elliot RubinIndependent Director | 318,00 | 0,00 | Derivative Exercise and Retained Stock | - | 232,55k | 0,14% |
| 2026-02-22 | Mr. Bradley S. PowellIndependent Director | 638,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,27k | 101,43% |
| 2026-02-22 | Ms. Emily DreyerChief Revenue Officer | 2,53k | 0,00 | Derivative Exercise and Retained Stock | - | 42,04k | 6,39% |
| 2026-02-22 | Ms. Emily DreyerChief Revenue Officer | -1,06k | 28,87k | Derivative Exercise and Sale | 27,16 | 42,04k | - |
| 2026-02-22 | Mr. Fawwad QureshiCFO | 4,65k | 0,00 | Derivative Exercise and Retained Stock | - | 4,65k | - |
| 2026-02-22 | Mr. Fawwad QureshiCFO | -1,83k | 49,68k | Derivative Exercise and Sale | 27,16 | 4,65k | - |
| 2026-02-22 | Mr. Asher Benjamin BearmanChief Legal Officer | 1,02k | 0,00 | Derivative Exercise and Retained Stock | - | 70,29k | 1,47% |
| 2026-02-22 | Mr. Asher Benjamin BearmanChief Legal Officer | -609,00 | 16,54k | Derivative Exercise and Sale | 27,16 | 70,29k | - |
| 2026-02-22 | Dr. Steve WeinrauchChief Veterinary & Product Officer | 3,49k | 0,00 | Derivative Exercise and Retained Stock | - | 71,86k | 5,11% |
| 2026-02-22 | Dr. Steve WeinrauchChief Veterinary & Product Officer | -1,47k | 39,93k | Derivative Exercise and Sale | 27,16 | 71,86k | - |
| 2026-02-22 | Mr. John GallagherCOO | 4,85k | 0,00 | Derivative Exercise and Retained Stock | - | 36,71k | 15,23% |
| 2026-02-22 | Mr. John GallagherCOO | -1,91k | 51,82k | Derivative Exercise and Sale | 27,16 | 36,71k | - |
| 2026-02-22 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | 11,80k | 0,00 | Derivative Exercise and Retained Stock | - | 162,09k | 7,85% |
| 2026-02-22 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -4,06k | 110,27k | Derivative Exercise and Sale | 27,16 | 162,09k | - |
| 2026-02-22 | Mr. Darryl Graham Andrew RawlingsFounder & Chair of the Board | 6,56k | 0,00 | Derivative Exercise and Retained Stock | - | 1,45M | 0,45% |
| 2026-01-28 | Mr. John GallagherCOO | -430,00 | 13,62k | Automatic Disposition | 31,67 | 31,86k | -1,33% |
| 2026-01-09 | Dr. Murray Bruce LowLead Independent Director | 23,21k | 198,94k | Derivative Exercise and Retained Stock | 8,57 | 154,53k | 17,68% |
| 2025-12-29 | Mr. John GallagherCOO | -430,00 | 16,15k | Automatic Disposition | 37,55 | 32,29k | -1,31% |
| 2025-12-19 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -8,00k | 231,56k | Derivative Exercise and Sale | 8,93 - 37,88 | 150,29k | - |
| 2025-12-19 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -1,61k | 60,84k | Automatic Disposition | 37,91 | 150,29k | -1,06% |
| 2025-11-28 | Mr. John GallagherCOO | -6,38k | 222,28k | Automatic Disposition | 34,82 | 32,72k | -16,32% |
| 2025-11-25 | Mr. Simon WheelerExec. VP of International Business | 688,00 | 0,00 | Derivative Exercise and Retained Stock | - | 21,33k | 3,33% |
| 2025-11-25 | Mr. Simon WheelerExec. VP of International Business | -608,00 | 21,50k | Derivative Exercise and Sale | 35,36 | 21,33k | - |
| 2025-11-25 | Ms. Emily DreyerChief Revenue Officer | 1,11k | 0,00 | Derivative Exercise and Retained Stock | - | 39,51k | 2,89% |
| 2025-11-25 | Ms. Emily DreyerChief Revenue Officer | -717,00 | 25,35k | Derivative Exercise and Sale | 35,36 | 39,51k | - |
| 2025-11-25 | Dr. Steve WeinrauchChief Veterinary & Product Officer | 701,00 | 0,00 | Derivative Exercise and Retained Stock | - | 68,37k | 1,04% |
| 2025-11-25 | Dr. Steve WeinrauchChief Veterinary & Product Officer | -224,00 | 7,92k | Derivative Exercise and Sale | 35,36 | 68,37k | - |
| 2025-11-25 | Mr. John GallagherCOO | 767,00 | 0,00 | Derivative Exercise and Retained Stock | - | 39,10k | 2,00% |
| 2025-11-25 | Mr. John GallagherCOO | -493,00 | 17,43k | Derivative Exercise and Sale | 35,36 | 39,10k | - |
| 2025-11-25 | Ms. Brenna McGibneyChief Administrative Officer | 303,00 | 0,00 | Derivative Exercise and Retained Stock | - | 6,09k | 5,23% |
| 2025-11-25 | Ms. Brenna McGibneyChief Administrative Officer | -344,00 | 12,16k | Derivative Exercise and Sale | 35,36 | 6,09k | - |
| 2025-11-25 | Mr. Fawwad QureshiCFO | -3,75k | 132,80k | Derivative Exercise and Sale | 35,36 - 35,45 | 0,00 | - |
| 2025-11-26 | Mr. Fawwad QureshiCFO | -3,93k | 139,20k | Automatic Disposition | 35,45 | 0,00 | -100,00% |
| 2025-11-25 | Mr. Darryl Graham Andrew RawlingsFounder & Chair of the Board | -946,00 | 42,29k | Derivative Exercise and Sale | 44,70 | 1,45M | - |
| 2025-11-25 | Mr. Darryl Graham Andrew RawlingsFounder & Chair of the Board | -29,42k | 1,32M | Verkauf | 44,70 | 1,45M | -1,99% |
| 2025-11-25 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | 4,52k | 0,00 | Derivative Exercise and Retained Stock | - | 151,90k | 3,06% |
| 2025-11-25 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -8,00k | 211,04k | Derivative Exercise and Sale | 8,93 - 35,31 | 151,90k | - |
| 2025-11-25 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -1,80k | 63,66k | Automatic Disposition | 35,31 | 151,90k | -1,17% |
| 2025-11-25 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -1,78k | 62,80k | Sale to Issuer | 35,36 | 151,90k | -1,16% |
| 2025-11-24 | Mr. Darryl Graham Andrew RawlingsFounder & Chair of the Board | 6,56k | 0,00 | Derivative Exercise and Retained Stock | - | 1,45M | 0,46% |
| 2025-11-24 | Mr. Bradley S. PowellIndependent Director | 629,00 | 0,00 | Derivative Exercise and Retained Stock | - | 629,00 | - |
| 2025-11-24 | Mr. Howard Elliot RubinIndependent Director | 318,00 | 0,00 | Derivative Exercise and Retained Stock | - | 232,23k | 0,14% |
| 2025-11-24 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | 9,62k | 0,00 | Derivative Exercise and Retained Stock | - | 150,96k | 6,80% |
| 2025-11-24 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -6,24k | 220,79k | Derivative Exercise and Sale | 35,40 | 150,96k | - |
| 2025-11-24 | Ms. Emily DreyerChief Revenue Officer | 2,56k | 0,00 | Derivative Exercise and Retained Stock | - | 38,40k | 7,15% |
| 2025-11-24 | Ms. Emily DreyerChief Revenue Officer | -1,03k | 36,36k | Derivative Exercise and Sale | 35,40 | 38,40k | - |
| 2025-11-24 | Mr. Simon WheelerExec. VP of International Business | 1,59k | 0,00 | Derivative Exercise and Retained Stock | - | 20,64k | 8,32% |
| 2025-11-24 | Mr. Simon WheelerExec. VP of International Business | -1,40k | 49,70k | Derivative Exercise and Sale | 35,40 | 20,64k | - |
| 2025-11-24 | Mr. John GallagherCOO | 5,95k | 0,00 | Derivative Exercise and Retained Stock | - | 38,34k | 18,38% |
| 2025-11-24 | Mr. John GallagherCOO | -3,41k | 120,54k | Derivative Exercise and Sale | 35,40 | 38,34k | - |
| 2025-11-24 | Ms. Brenna McGibneyChief Administrative Officer | 2,09k | 0,00 | Derivative Exercise and Retained Stock | - | 5,79k | 56,30% |
| 2025-11-24 | Ms. Brenna McGibneyChief Administrative Officer | -2,40k | 84,92k | Derivative Exercise and Sale | 35,40 | 5,79k | - |
| 2025-11-24 | Mr. Fawwad QureshiCFO | 3,93k | 0,00 | Derivative Exercise and Retained Stock | - | 3,93k | - |
| 2025-11-24 | Mr. Fawwad QureshiCFO | -2,55k | 90,09k | Derivative Exercise and Sale | 35,40 | 3,93k | - |
| 2025-11-24 | Dr. Steve WeinrauchChief Veterinary & Product Officer | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 67,67k | 5,87% |
| 2025-11-24 | Dr. Steve WeinrauchChief Veterinary & Product Officer | -1,21k | 42,73k | Derivative Exercise and Sale | 35,40 | 67,67k | - |
| 2025-11-20 | Mr. Darryl Graham Andrew RawlingsFounder & Chair of the Board | 2,00k | 29,90k | Derivative Exercise and Retained Stock | 14,95 | 27,22k | 7,93% |
| 2025-10-27 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -6,00k | 208,76k | Derivative Exercise and Sale | 8,93 - 43,72 | 141,35k | - |
| 2025-10-27 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -2,88k | 126,15k | Automatic Disposition | 43,74 | 141,35k | -2,00% |
| 2025-09-25 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -2,96k | 124,00k | Automatic Disposition | 41,88 | 144,23k | -2,01% |
| 2025-09-25 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -6,00k | 197,74k | Derivative Exercise and Sale | 8,93 - 41,89 | 144,23k | - |
| 2025-02-27 | Mr. Howard Elliot RubinIndependent Director | 641,00 | 0,00 | Derivative Exercise and Retained Stock | - | 231,91k | 0,28% |
| 2025-09-03 | Mr. Darryl Graham Andrew RawlingsFounder & Chair of the Board | -19,63k | 879,23k | Verkauf | 44,79 | 1,44M | -1,35% |
| 2025-09-02 | Mr. Fawwad QureshiCFO | -6,45k | 291,29k | Automatic Disposition | 45,15 | 0,00 | -100,00% |
| 2025-05-22 | Mr. Darryl Graham Andrew RawlingsFounder & Chair of the Board | 15,02k | 0,00 | Derivative Exercise and Retained Stock | - | 1,49M | 1,02% |
| 2025-08-25 | Dr. Steve WeinrauchChief Veterinary & Product Officer | 701,00 | 0,00 | Derivative Exercise and Retained Stock | - | 63,91k | 1,11% |
| 2025-08-25 | Dr. Steve WeinrauchChief Veterinary & Product Officer | -223,00 | 10,22k | Derivative Exercise and Sale | 45,83 | 63,91k | - |
| 2025-08-25 | Ms. Emily DreyerChief Revenue Officer | 1,38k | 0,00 | Derivative Exercise and Retained Stock | - | 35,84k | 4,01% |
| 2025-08-25 | Ms. Emily DreyerChief Revenue Officer | -443,00 | 20,30k | Derivative Exercise and Sale | 45,83 | 35,84k | - |
| 2025-08-25 | Mr. John GallagherCOO | 956,00 | 0,00 | Derivative Exercise and Retained Stock | - | 32,38k | 3,04% |
| 2025-08-25 | Mr. John GallagherCOO | -303,00 | 13,89k | Derivative Exercise and Sale | 45,83 | 32,38k | - |
| 2025-08-25 | Ms. Brenna McGibneyChief Administrative Officer | 303,00 | 0,00 | Derivative Exercise and Retained Stock | - | 3,71k | 8,91% |
| 2025-08-25 | Ms. Brenna McGibneyChief Administrative Officer | -343,00 | 15,72k | Derivative Exercise and Sale | 45,83 | 3,71k | - |
| 2025-08-25 | Mr. Fawwad QureshiCFO | -3,75k | 171,33k | Derivative Exercise and Sale | 45,56 - 45,83 | 6,45k | - |
| 2025-08-26 | Mr. Fawwad QureshiCFO | -829,00 | 37,77k | Automatic Disposition | 45,56 | 6,45k | -11,39% |
| 2025-08-25 | Mr. Simon WheelerExec. VP of International Business | 688,00 | 0,00 | Derivative Exercise and Retained Stock | - | 19,06k | 3,75% |
| 2025-08-25 | Mr. Simon WheelerExec. VP of International Business | -608,00 | 27,86k | Derivative Exercise and Sale | 45,83 | 19,06k | - |
| 2025-08-25 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | 2,74k | 0,00 | Derivative Exercise and Retained Stock | - | 147,19k | 1,90% |
| 2025-08-25 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -1,78k | 81,35k | Derivative Exercise and Sale | 45,83 | 147,19k | - |
| 2025-08-22 | Mr. John GallagherCOO | 4,46k | 0,00 | Derivative Exercise and Retained Stock | - | 31,43k | 16,55% |
| 2025-08-22 | Mr. John GallagherCOO | -1,44k | 66,91k | Derivative Exercise and Sale | 46,63 | 31,43k | - |
| 2025-08-22 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | 15,15k | 0,00 | Derivative Exercise and Retained Stock | - | 144,45k | 11,72% |
| 2025-08-22 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -9,83k | 458,33k | Derivative Exercise and Sale | 46,63 | 144,45k | - |
| 2025-08-22 | Dr. Steve WeinrauchChief Veterinary & Product Officer | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 63,21k | 6,31% |
| 2025-08-22 | Dr. Steve WeinrauchChief Veterinary & Product Officer | -1,21k | 56,24k | Derivative Exercise and Sale | 46,63 | 63,21k | - |
| 2025-08-22 | Ms. Brenna McGibneyChief Administrative Officer | 2,09k | 0,00 | Derivative Exercise and Retained Stock | - | 3,40k | 158,31% |
| 2025-08-22 | Ms. Brenna McGibneyChief Administrative Officer | -2,40k | 111,91k | Derivative Exercise and Sale | 46,63 | 3,40k | - |
| 2025-06-02 | Ms. Brenna McGibneyChief Administrative Officer | -2,39k | 107,96k | Verkauf | 45,17 | 3,40k | -41,26% |
| 2025-08-22 | Mr. Fawwad QureshiCFO | 3,74k | 0,00 | Derivative Exercise and Retained Stock | - | 7,28k | 105,36% |
| 2025-08-22 | Mr. Fawwad QureshiCFO | -2,74k | 127,72k | Derivative Exercise and Sale | 46,63 | 7,28k | - |
| 2025-08-22 | Mr. Simon WheelerExec. VP of International Business | 1,59k | 0,00 | Derivative Exercise and Retained Stock | - | 18,37k | 9,46% |
| 2025-08-22 | Mr. Simon WheelerExec. VP of International Business | -1,40k | 65,47k | Derivative Exercise and Sale | 46,63 | 18,37k | - |
| 2025-08-22 | Ms. Emily DreyerChief Revenue Officer | 2,72k | 0,00 | Derivative Exercise and Retained Stock | - | 34,46k | 8,56% |
| 2025-08-22 | Ms. Emily DreyerChief Revenue Officer | -873,00 | 40,71k | Derivative Exercise and Sale | 46,63 | 34,46k | - |
| 2025-06-06 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -200,00 | 8,16k | Derivative Exercise and Sale | 7,78 - 48,57 | 129,30k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
